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Abstract
Background: Current evidence suggests that endometrial-derived stem cells, spilled in the peritoneal cavity via
retrograde menstruation, are key players in the establishment of endometriotic lesions. The aim of this study was
to determine the presence and distribution of the stemness-related factors OCT4, SOX15, TWIST1 and DCAMLK1 in
women with and without endometriosis.
Methods: Immunohistochemical analysis was used to determine stromal and epithelial expression of OCT4, SOX15,
TWIST1 and DCAMLK1 in endometriosis patient (EP) endometrium (n = 69) and endometriotic tissue (n = 90) and in
control endometrium (n = 50). Quantitative Real-Time PCR of OCT4, SOX15 TWIST1 and DCAMLK1 was performed in
paired samples of EP endometrium and endometriotic tissue. Co-immunofluorescence staining was performed for
OCT4 and SOX15. For statistical analyses we used unpaired t-test, Fisher combination test and Spearman test. For
paired analyses, paired t-test and McNemar test were used.
Results: We detected a significant correlation between the expression of the established stem cell marker OCT4
and the stemness-related markers SOX15 (p < 0.001) and TWIST1 (p = 0.002) but not DCAMLK1. We showed a
colocalization of SOX15 and OCT4 in epithelial and stromal cells of endometriotic tissue by coimmunofluorescence.
A concordant expression of OCT4 and SOX15 in the same sample was observed in epithelial cells of the
endometriotic tissue (71.7%). The expression of stemness-related factors was not associated with proliferative or
secretory phase of the menstrual cycle in endometriosis patients but was found to be differentially expressed
during the menstrual cycle in the control group. Increased expression of epithelial OCT4, SOX15 and TWIST1 was
detected in endometriotic tissue compared to EP endometrium in paired (p = 0.021, p < 0.001 and p < 0.001) and
unpaired analysis (p = 0.040, p < 0.001 and p = 0.001).
Conclusion: Our findings support the hypothesis that upregulation of stem cell-related factors contribute to the
establishment of endometriotic lesions.
Trial registration: The study was approved by the institutional review board (545/2010 on 6th of May 2014) of the
Medical University of Vienna (http://ethikkommission.meduniwien.ac.at/fileadmin/ethik/media/dokumente/register/
alle_2010.pdf).
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Background
Endometriosis is a benign gynecological disease, which is
characterized by the presence of functional endometrial
glands and stroma outside the uterine cavity [1]. The exact
aetiology of endometriosis is unclear. One widely accepted
hypothesis is that endometriosis originates from retro-
grade menstruation of endometrial cells which implant on
peritoneal surfaces [2]. During the reproductive life of
women the endometrium undergoes profound changes
according to the different phases of the menstrual cycle
[3]. Several studies revealed the presence of adult stem
cells in the basalis layer as well as functionalis layer of the
human endometrium [4–7]. These endometrium-derived
stem cells, which are distributed by retrograde menstrual
efflux, may contribute to the establishment of ectopic
endometriotic lesions [7–11]. The monoclonal origin of
some endometriotic lesions, long-time culture properties
of cell clones established from endometriotic lesions and
the isolation of progenitor cells from menstrual blood sup-
port this hypothesis [12–17].
Recent studies have been evaluating candidate markers
for endometrial progenitor stem cells. Several general
adult stem cell markers, such as bcl-2, c-kit (CD117),
CD34 and noteworthy OCT4 have been identified in
human endometrial tissue samples [4, 7, 18–22]. The
transcription factor OCT4 is crucial for the mainten-
ance of cell pluripotency and is known to be expressed
in embryonic stem cells, germ cells and in adult stem
cells [7, 23]. Furthermore, in vitro studies have shown
that elevated expression of OCT4 and SOX2 in human
endometrial cells contributed to reprogramming these
cells into induced pluripotent stem cells (iPS cells)
suggesting that OCT4 and SOX2 are stemness-related
factors in human endometrium [24]. In endometriosis,
the epithelial expression of OCT4 evaluated by immu-
nohistochemistry was significantly higher in ectopic
lesions compared to eutopic endometrium of patients
with and without endometriosis. [25, 26]. Although the
transcription factor OCT4 is a known key modulator
for stem cell properties of primate stem cells, it further
forms complexes with many different partners and
displays various functions [27]. Several SOX-OCT tran-
scription factor combinations have been identified and
the cooperation correlates with the efficiency in producing
iPS cells [28]. SOX15 for example strongly cooperates
with OCT4 on the canonical pathway and has not been
investigated in endometriosis so far [28].
The aim of this study was to analyze the role of stem
cell-related markers in endometriosis. We correlated
the expression of SOX15 and the potential stem cell
factors TWIST1 (twist family bHLH transcription factor 1)
and DCAMLK1 (doublecortin- and calmodulin kinase-like
1) with OCT4 expression. We analyzed the coexpression
of SOX15 and OCT4 in epithelial and stromal cells of
endometriotic lesions. Further we investigated the expres-
sion of stemness-related factors during the proliferative
and secretory phase of the menstrual cycle, in patients with
and without endometriosis and in different stages of
endometriosis.
Methods
Patients and tissue samples
Tissue samples were obtained from 160 premenopausal
women (mean age 34.5 ± 6.4 years), who underwent
surgery at the General Hospital of Vienna between 2010
and 2014 due to the suspicion of endometriosis with or
without infertility, chronic pelvic pain, benign adnexal
masses, or uterine leiomyoma. The tissue samples have
been collected in the context of a prospective cohort study
called EMMA Study (EndoMetriosisMarkerAustria). The
160 cases consisted of 110 patients with endometriosis
and 50 control patients who underwent laparoscopy and
endometrial sampling with or without hysteroscopy due
to benign adnexal masses, chronic pelvic pain or uterine
fibroids. Exclusion criteria were pregnancy or breastfeed-
ing less than 6 months prior to the beginning of the study,
malignant disease, infectious diseases (HIV, hepatitis A, B
and C, tuberculosis) and autoimmune diseases. Among
the 110 cases with endometriosis, we obtained matched
samples of endometriotic and eutopic endometrium in 49
cases, exclusively endometriosis patient (EP) endometrium
in 20 cases, and exclusively endometriotic tissue in 41
cases. The study was approved by the institutional review
board (545/2010) of the Medical University of Vienna. All
participants provided written informed consent. The
matched sample tissues were collected during the same
surgical procedure. Tissues were sliced in two. One part
of the sample was snap-frozen in liquid nitrogen (LN2)
immediately after surgical extraction and stored at -80°
Celsius to minimize enzymatic degradation until final ana-
lysis. The other part of the tissue was fixed in 4% buffered
formalin immediately after surgical extraction and stored
overnight for processing of immunohistochemical ana-
lysis. Endometriosis was diagnosed histologically in all
endometriosis patients. Staging was performed according
to the revised American Fertility Society (rAFS) classifica-
tion guidelines (I, n = 17; II, n = 23; III, n = 22; IV, n = 25)
[29]. Cycle phase was determined by histopathological
examination of endometrial samples by an experienced
pathologist and was confirmed by date of last menstrual
period.
Characteristics of the study populations are provided
in Table 1.
Quantitative Real-Time PCR (qRT-PCR)
Briefly, total RNA was isolated from fresh frozen tissues
with the Absolutely RNA miRNA Kit (Agilent, CA, USA)
and reverse-transcribed with the SuperScript First-Strand
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Kit (Invitrogen, CA, USA) according to the manufac-
turers’ instructions. Each sample was analyzed by real-
time PCR on an Applied Biosystems 7500 fast instrument,
using gene-specific primers and fluorescent probes ob-
tained from Applied Biosystems (CA, USA): OCT4,
Hs00999632_g1; SOX15, Hs_00199511_m1; TWIST1,
Hs_01675818_m1; DCAMLK1, Hs00178027_m1; GAPDH
(control), Hs_99999905_m1, and ACTB (control),
Hs_99999903_m1. The mRNA levels of OCT4, SOX15,
TWIST1 and DCAMLK1 were normalized to those of
ACTB and GAPDH in each sample by subtracting the
mean Ct (threshold cycle) values of the controls from the
Ct value of OCT4, SOX15,TWIST1 and DCAMLK1 as
described previously [30]. For binary analysis, the cutoff
was set at the median levels for SOX15 and TWIST1
expression.
Immunohistochemistry (IHC)
Immunohistochemical staining was performed on formalin-
fixed, paraffin-embedded tissues. Three-micrometer thick
sections were cut and placed on glass slides. Heat anti-
gen retrieval was performed in 10mM Sodium Citrate
Buffer pH6. Nonspecific background staining was blocked
by incubating in H2O2 and with Ultra V Block (Thermo
Scientific, Ultra Vision LP Kit, TL-060-HL, MA, USA)
according to the protocol. The following antibodies were
used: the rabbit polyclonal anti-TWIST antibody (Abcam,
ab50581, Cambridge, UK) was applied at a dilution of
1:1200 with Antibody Diluent with Background Reducing
Components (Dako, S3022, Glostrup, Denmark), the
mouse monoclonal anti-DCAMKL1 antibody (Abcam,
ab88484, Cambridge, UK) at a dilution of 1:500, the rabbit
monoclonal anti-OCT4 antibody (Abcam, ab109183,
Cambridge, UK) at a dilution of 1:500, and the rabbit
polyclonal anti-SOX15 (Abcam, ab55960, Cambridge,
UK) at a dilution of 1:300. Ultra Vision LP Kit was used
for detection according to the protocol (Thermo Scientific,
Ultra Vision LP Kit, TL-060-HL, MA, USA). Finally, all
slides were incubated with DAB-Substrate (Dako, K346811,
Glostrup, Denmark) and counterstained in Hematoxylin
before they were dehydrated and mounted.
Scoring and Immunohistochemical Analysis
Prior to immunohistochemistry, endometriotic lesions
consisting of well-defined glandular epithelial and stro-
mal cells were identified in hematoxylin-eosin stained
sections by a pathologist. Serial sections were cut from
the chosen samples. A semiquantitative subjective scoring
system to evaluate the localization, quantity and intensity
of immunoreactivity was employed using light microscopy
(200x magnification). In each sample, the staining for
glandular epithelial cells and stromal cells was scored
separately. The intensity of the staining was scored
using a four-point scoring scale (0, negative staining; 1,
weak staining; 2 moderate staining, 3, strong staining).
The percentage of positively stained cells was again
scored by a four-point scoring scale (0, negative stain-
ing; 1, 1-35% positive cells; 2, 36-70% positive cells; 3,
>67% positive cells). The two scores were combined by
multiplication to derive a final IHC score (0-9). For bin-
ary analysis, the cutoff was set at the median level of
the final IHC score. Evaluations were performed in
blind by two investigators. Positive (Seminoma) and
negative (without primary antibody) controls were run
concurrently. OCT4 (Fig. 1a, b) and SOX15 proteins
(Fig. 1c, d) were expressed in the nucleus of the epithe-
lial and the stromal cells of eutopic and ectopic endo-
metrium. TWIST1 expression was observed in the
cytoplasm and nucleus of epithelial and stromal cells
(Fig. 1e, f ). However, as a transcription factor, activated
TWIST1 exerts its main function in the nucleus. Thus,
for TWIST1, only nuclear staining of epithelial and
stromal cells was evaluated. DCAMLK1 protein was
expressed in the cytoplasm of the epithelial and stromal
cells in eutopic and ectopic endometrium (Fig. 1g, h).
Confocal Immunofluorescence Studies
Immunofluorescence staining was performed on formalin-
fixed, paraffin-embedded tissue. Heat Antigen Retrieval
Table 1 Description of the study population
Endometriosis patients (EP, n = 110)
Total Control endometrium (n = 50) Eutopic endometrium (n = 69) Endometriotic tissue (n = 90)
Age (years) 209 34.9 ± 5.8 33.1 ± 6.1 34.7 ± 6.8
Cycle Phase Proliferative 99 24 (48.0%) 31 (44.9%) 44 (48.9%)
Secretory 92 20 (40.0%) 37 (53.6%) 35 (38.9%)
na 18 6 (12.0%) 1 (1.4%) 11 (12.2%)
Staging I or II 62 22 (31.9%) 40 (44.4%)
III or IV 72 25 (36.2%) 47 (52.2%)
na 25 22 (31.9%) 3 (3.3%)
EP Endometriosis patient. Numbers of patients in each of the indicated subgroups are shown. Numbers in parentheses indicate the fraction of patients (%) in each
column in proliferative and secretory cycle phase or with low and high stage [28]. na, status not available
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was performed in 10mM Sodium Citrate Buffer pH6.
Nonspecific background staining was blocked by incu-
bating in 0.05% fish skin in PBS. The rabbit polyclonal
anti-SOX15 antibody (Abcam, ab55960, Cambridge,
UK) and the mouse monoclonal anti-OCT4 antibody
(Abcam, ab184665, Cambridge, UK) were applied at a
dilution of 1:100 and incubated over night at 4°C. Sec-
ondary antibodies from Alexa (life technologies CA,
USA, goat anti-mouse IgG: Fluor 546 (red), A-11018,
goat anti-rabbit IgG, Fluor 488 (green), A11070) were
diluted 1:1000 with 0.05% fish skin and incubated with
1μg/ml DAPI at room temperature for one hour. The
slides were mounted with Fluoromount-G (Southern
Biotech 0100-01, AL, USA). Colocalization of SOX15
and OCT4 was analyzed at 630x and 945x magnifica-
tion using a Zeiss LSM 700 photomicroscope and LSM
software (Zeiss, Göttingen, Germany).
Statistical analysis
Data were analyzed using SPSS (17.0, IBM Corp., NY,
USA). For correlation analysis, Spearman test was used.
For paired statistics, the McNemar test and paired t-test
were used. Unpaired Student t-test was used to compare
two groups. To account for repeated measures we com-
pared expression differences between EP endometrium
and endometriotic tissue using separate tests in the paired
(paired t-test) and unpaired patient subsets (Welch t-test).
To obtain a p-value for the overall comparison between
EP endometrium and endometriotic tissue the resulting p-
values were combined using Fisher combination test [31].
Analyses for the Fisher combination tests were performed
using R software (R-project.org). We consider the sub-
group analyzes as exploratory, and hence did not adjust
for multiple testing, as recommended by Bender and
Lange [32]. Statistical significance was defined as p < 0.05.
Fig. 1 Immunohistochemical analyses of OCT4, SOX15, TWIST1 and DCAMLK1 in eutopic and ectopic endometrium. Anti-OCT4 and anti-SOX15
antibodies were applied at a dilution of 1:500 and 1:300, respectively, and yielded nuclear staining in eutopic (a, c) or ectopic tissue (b, d). Anti-TWIST1
antibody was applied at a dilution of 1:1200 and yielded cytoplasmatic and nuclear staining in eutopic (e) and ectopic (f) lesions. For evaluation, only
nuclear staining was analyzed. Anti-DCAMLK1 antibody was applied at a dilution of 1:500 and yielded cytoplasmatic staining in eutopic (g) or ectopic
tissue (h). Magnification = 200x
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Results
Increased OCT4 expression in epithelium of
endometriotic tissue
In a first step we investigated the OCT4 expression in
EP endometrium and endometriotic tissue. Analysis of
the 49 endometriosis cases with paired samples (i.e. con-
comitant EP endometrium and endometriotic tissue)
demonstrated a significant increase of OCT4 in glandu-
lar epithelium of endometriotic tissue (p = 0.021; paired
t-test, Fig. 2a). No significant difference was found in the
stroma (Fig. 2a). In a next step we compared the samples
of the whole cohort of 110 endometriosis patients
(including unpaired cases) with the 50 control cases.
Similarly, epithelial OCT4 expression was significantly
increased in endometriotic tissue compared to EP endo-
metrium (p = 0.040, Fisher combination test, Fig. 3a) and
control endometrium (p = 0.006, t-test, Fig. 3a). The
stroma showed no significant differences (Fig. 3a). Similar
to the epithelial protein expression of OCT4, OCT4
mRNA expression was significantly increased in endome-
triotic tissue compared to EP endometrium of paired
samples (p = 0.038; paired t-test, Fig. 4a). Therefore we
concluded that OCT4 is overexpressed in the epithelium
of endometriotic tissue.
Increased SOX15 expression in epithelium of
endometriotic tissue
Next we analyzed SOX15 expression. Similar to OCT4,
SOX15 expression was significantly increased in the
epithelium of endometriotic tissue compared to EP endo-
metrium (paired samples p < 0.001; paired t-test, Fig. 2b;
whole cohort including unpaired samples p < 0.001; Fisher
combination test, Fig. 3b). SOX15 was also significantly
increased in the epithelium of endometriotic tissue com-
pared to control endometrium (p = 0.029; t-test, Fig. 3b).
The analysis of stromal SOX15 expression revealed no
significant difference in paired samples (Fig. 2b). In
contrast to the paired samples, significant differences
were found for stromal SOX15 when investigating all
cases (endometriotic tissue vs EP endometrium p = 0.030,
Fisher combination test, Fig. 3b; EP endometrium vs
control endometrium p < 0.001, t-test, Fig. 3b; endome-
triotic tissue vs. control endometrium p = 0.003, t-test,
Fig. 3b). Similar to the epithelial protein expression of
SOX15, SOX15 mRNA expression was significantly in-
creased in endometriotic tissue compared to EP endo-
metrium of paired samples (p = 0.004; paired t-test,
Fig. 4b; p = 0.041; McNemar, Table 2). We concluded
that - similar to OCT4 – SOX15 is significantly overex-
pressed in the epithelium of the endometriotic tissue.
Increased TWIST1 expression in epithelium of
endometriotic tissue
The analysis of TWIST1 revealed that TWIST1 expres-
sion was significantly increased in the epithelium of endo-
metriotic tissue (paired samples p < 0.001; paired t-test,
Fig. 2c; all endometriosis patients including the unpaired
samples p = 0.001; Fisher combination test, Fig. 3c). The
Fig. 2 Expression analyses in 49 paired cases with endometriosis. IHC was used to analyze the protein expression of OCT4 (a), SOX15 (b), TWIST1
(c) and DCAMLK1 (d). Results are expressed as mean score of the immunohistochemical staining ± SD. Epithelial and stromal expression was analyzed
separately. All p-values of paired comparisons were analysed by paired t-test
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Fig. 3 Expression analyses in 50 control patients, and 110 patients with endometriosis (eutopic and ectopic). IHC was used to analyze the protein
expression of OCT4 (a), SOX15 (b), TWIST1 (c) and DCAMLK1 (d). Results are expressed as mean score of the immunohistochemical staining ± SD.
Epithelial and stromal expression was analyzed separately. Comparisons with the control group were analysed by t-test, comparisons between EP
endometrium and endometriotic tissue were performed using Fisher combination test
Fig. 4 Relative mRNA expression levels in 49 paired cases with endometriosis. Quantitative Real Time PCR was used to analyze the mRNA expression
levels of OCT4 (a), SOX15 (b), and TWIST1 (c). Expression levels were normalized to ß-actin and GAPDH. Expression levels were shown as mean ± SD.
All p-values were analysed by paired t-test
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analysis of stromal TWIST1 expression revealed no
significant differences between endometriotic tissue and
EP endometrium in paired and unpaired analysis (Fig. 2c,
Fig. 3c). Further a higher stromal TWIST1 expression was
found in the control endometrium compared to EP
endometrium and endometriotic tissue (both p < 0.001,
Fig. 3c). A higher epithelial TWIST1 expression was
found in the control endometrium compared to EP endo-
metrium (p = 0.001, Fig. 3c). Similar to the epithelial pro-
tein expression of TWIST1, TWIST1 mRNA expression
was significantly increased in endometriotic tissue com-
pared to EP endometrium of paired samples (p = 0.029;
paired t-test, Fig. 4c).
In conclusion, epithelial TWIST1, SOX15, and OCT4
are overexpressed in endometriotic tissue compared to
EP endometrium of paired and unpaired endometriosis
samples. No significant differences were found in the
stroma of the paired endometriosis cases.
Reduced DCAMLK1 expression in endometriotic tissue
In the analysis of endometriosis patients, epithelial and
stromal DCAMLK1 expression was found to be signifi-
cantly reduced in endometriotic tissue compared to EP
endometrium in paired (stromal: p < 0.001; paired t-test,
Fig. 2d) and unpaired samples (epithelial: p = 0.019, stro-
mal: p < 0.001; Fisher combination test, Fig. 3d). In the
comparison of endometriosis and control patients,
epithelial and stromal DCAMLK1 expression was sig-
nificantly increased in EP endometrium (epithelial: p =
0.026; stromal: p = 0.017, t-test, Fig. 3d). The mRNA levels
of DCAMLK1 determined by qRT-PCR were very low in
all samples and occasionally below detection level (Add-
itional file 1). We concluded that DCAMLK1 is down-
regulated in ectopic endometrium. This is in contrast to
the findings for OCT4, SOX15, and TWIST.
OCT4, SOX15 and TWIST1 but not DCAMLK1 expressions
are positively correlated in endometriotic tissue
Next we correlated the four markers. A positive correlation
was observed between epithelial OCT4 and epithelial
SOX15 expression in endometriotic tissue (p < 0.001,
Spearman’s rho 0.434, Table 3). Epithelial OCT4 expression
also significantly correlated, although to a lower degree,
with epithelial TWIST1 expression in endometriotic tissue
(Spearman’s rho 0.336, p = 0.002, Table 3). A significant but
very low correlation was also shown between ectopic
epithelial SOX15 and TWIST1 expression (p = 0.019,
Spearman’s rho 0.253, Table 3). No significant correlations
were shown between DCAMLK1 and OCT4, SOX15 or
TWIST1 in endometriotic tissue (Table 3). Thus we con-
cluded that OCT4 predominately correlated with SOX15
expression.
Concordant expression of OCT4 and SOX15
We analyzed the concurrent expression of OCT4 and
SOX15. 71.7% (33/46) of endometriotic samples of the
endometriosis cohort showing positive epithelial expres-
sion of OCT4 simultaneously showed positive epithelial
staining for SOX15 (data not shown). In stromal cells of
endometriotic tissue, 57.8% (26/45) of the samples with
positive OCT4 staining also showed positive SOX15
expression (data not shown). There was no significant
difference between SOX15 and OCT4 expression in the
epithelium (p = 0.584, McNemar) or stroma (p = 0.643,
McNemar) analyzed in the same endometriotic tissue
sample (data not shown).
Confocal immunofluorescence microscopy revealed nu-
clear staining of epithelial SOX15, which mostly coloca-
lized with epithelial OCT4. Some stromal cells showed
OCT4 staining without SOX15 expression (white arrows,
Fig. 5). Similarly to OCT4 and SOX15 expression, TWIST1
and SOX15 mRNA were also expressed concordantly. Best
concordance was observed in endometriotic tissue where
73.8% (31/42) of SOX15 mRNA positive samples were also
positive for TWIST1 mRNA expression (data not shown).
There was no significant difference between SOX15 and
TWIST1 mRNA expression in the same endometriotic tis-
sue sample (p = 0.839, McNemar, data not shown).
Expression of epithelial OCT4, SOX15 and TWIST1 does
not correlate with cycle phase in patients with
endometriosis nor with endometriosis staging
No significant difference in OCT4, SOX15, TWIST1 or
DCAMLK1 expression was observed between proliferative
and secretory phase neither in EP endometrium nor in
endometriotic tissue (data not shown). In contrast, in con-
trol endometrium epithelial expression of DCAMLK1 is
higher in patients in proliferative cycle phase than in
secretory phase (p < 0.001, t-test, Fig. 6). The expression
levels of epithelial TWIST1 and OCT4 are significantly
reduced in the proliferative phase of control patients
(p = 0.031 and p = 0.006, t-test, Fig.6). The epithelial
expression of SOX15 is also reduced in proliferative
phase of control patients, however at a non-significant
level (Fig. 6).
Table 2 SOX15 mRNA expression in EP endometrium and
endometriotic tissue of the same patient
SOX15 mRNA in endometriotic tissue
Total neg pos P-value
SOX15 mRNA in EP
endometrium
neg 17 2 (11.8%) 15 (88.2%) 0.041
pos 12 5 (41.7%) 7 (58.3%)
Numbers of patients in each of the indicated subgroups are shown. Numbers
in parentheses indicate the fraction of patients (%) in each row in ectopic
endometriotic lesions negative and positive for SOX15. All p-values of subgroup
comparisons were analysed by McNemar Test
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No significant difference in OCT4, SOX15, TWIST1
or DCAMLK1 expression was observed between the
different stages of endometriosis according to the rAFS
classification.
Discussion
In the present study we document the possible import-
ance of stem cells for the development of endometriosis
through the analysis of four stemness-related markers
in EP endometrium, control endometrium and endo-
metriotic tissue. Functional analyses of stem cell prop-
erties in endometriotic cells are quite limited. However,
elevated expression of OCT4 and SOX2 in human
endometrial cells contributed to reprogramming these
cells into pluripotent stem cells (iPS cells) suggesting
that OCT4 and SOX2 are stem cell factors in human
endometrium [24]. SOX-OCT transcription factor com-
binations correlate with the efficiency in producing iPS
Table 3 Spearman’s correlation between the epithelial expression
of OCT4, SOX15, TWIST1 and DCAMLK1 in endometriotic tissue
OCT4 SOX15 TWIST1 DCAMLK1
OCT4 Corr. Coefficient 1 0.434 0.336 0.078
Sig. (2-tailed) 2.63 × 10-5 0.002 0.477
n 88 87 85 85
SOX15 Corr. Coefficient 1 0.253 0.072
Sig. (2-tailed) 0.019 0.513
n 89 85 86
TWIST1 Corr. Coefficient 1 0.14
Sig. (2-tailed) 0.204
n 86 84
DCAMLK1 Corr. Coefficient 1
Sig. (2-tailed)
n 87
Expression of all factors was determined by immunohistochemistry. Correlation
Coefficients and p-values with statistically significant p-values were emphasised Bold.
Fig. 5 Colocalization of OCT4 and SOX15 in human endometriotic tissue. Paraffin sections of human endometrium were processed for
immunofluorescence microscopy. OCT4 (a), SOX15 (b), and DAPI (c) stainings are shown. OCT4/SOX15 merged picture (d) denotes
colocalization in all epithelial cells whereas few stromal cells were only positive for OCT4 (white arrows)
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cells. Thus we also analyzed a potential correlation and
coexpression of OCT4 and SOX15, since SOX15 pro-
tein expression has never been studied in endometriosis
[28]. We studied OCT4 and SOX15 expression in 110
cases and confirmed a positive correlation and overex-
pression of both factors in the epithelium of endome-
triotic tissue. Our findings are in line with previous
studies with smaller sample sizes reporting an increased
expression of stemness-related markers in endometri-
osis [25, 26]. SOX2 expression has been shown to be
significantly increased in endometriosis compared to
secretory endometrium of patients without endometriosis
[33]. Musashi-1, an epithelial progenitor cell marker
regulating self-renewal pathways, was also found to be
overexpressed in endometriotic tissue compared to
eutopic endometrium of controls [34]. SALL4, which is
a transcriptional regulator of OCT4 and a marker for
pluripotency, has been shown to be expressed in endo-
metriotic tissue but not in EP endometrium [26]. Inter-
estingly, SOX15 and TWIST1 expression was lower in
EP endometrium compared to the control endomet-
rium. These factors may be upregulated in endometrial
cells after dissemination to promote cell survival and
invasion predominantly outside the uterine cavity in
order to form endometriotic lesions.
The enhanced expression of stemness-related markers in
endometriotic tissue may foster self-renewal and increase
cell survival. Analysis of eutopic endometrial cells collected
from the menstrual blood of patients with and without
endometriosis revealed that endometriosis patients had
higher mRNA expression of OCT4 and SOX2 than nor-
mal controls [35]. Furthermore, women with endomet-
riosis have larger volumes of retrograde menstrual flow
than women without endometriosis and baboons whose
cervices had been ligated showed a significant increase
in development of endometriosis [36, 37]. Thus, our
findings may support the hypothesis that cells with
stem cell capacity, disseminated into the peritoneal cav-
ity via retrograde menstrual efflux, may accumulate and
contribute to the establishment of ectopic endometrio-
tic lesions [7–11]. However, another proposal concern-
ing the histologic origin of endometriosis is that
circulating blood cells originating from bone marrow
can differentiate into endometriotic tissue at various
sites [38]. According to this, a small number of the ac-
cumulated stem cells shown in the endometrium of
endometriosis patients may also derive from bone mar-
row. Moreover, it is unclear if increased stem cell num-
ber or even abnormal stem cell properties facilitate the
establishment of ectopic endometrial implants in pa-
tients developing endometriosis.
We and others found an overexpression of TWIST1 in
ectopic endometrium [39, 40]. TWIST1 is a marker for
epithelial to mesenchymal transition (EMT), and increases
the migratory activity of endometrial cells [39]. Recent
evidence suggest that cells undergoing EMT acquire stem
cell-like properties and the mesenchymal status seems to
be a condition to regain pluripotency [41]. Thus, TWIST1
could be another potential stemness-related marker in hu-
man endometrium.
DCAMLK1, a microtubule-associated kinase, is a
putative stem cell marker in pancreas and intestine,
which regulates TWIST1, MYC, KRAS and other fac-
tors. DCAMLK1 was identified as a novel pancreatic
cancer stem cell marker [42]. Interestingly, DCAMLK1
has the capacity to distinguish between normal and
tumor stem cells at least in the intestine [43]. So far, no
study has analyzed the expression of DCAMLK1 in
endometriosis. Surprisingly, we found significant results
for DCAMLK1 with an ectopic expression pattern in-
verse to OCT4. Stromal and epithelial DCAMLK1 ex-
pression was significantly higher in EP endometrium
than in endometriotic tissue. The expression of stromal
and epithelial DCAMLK1 was significantly increased in
EP endometrium compared to control endometrium.
This finding suggests that in endometriosis patients
DCAMLK1 is upregulated in cells of the uterine cavity
before dissemination into the peritoneal cavity. The up-
regulation of DCAMLK1 in EP endometrium may be
due to enhanced posttranslational stabilization of the
protein as the mRNA levels of DCAMLK1 were very
Fig. 6 Expression levels of epithelial OCT4, SOX15, TWIST1 and
DCAMLK1 in proliferative and secretory phase of the menstrual
cycle in control patients. Results are expressed as mean scores of
the immunohistochemical stainings ± SD. All p-values of subgroup
comparisons were analysed by t-test
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low. Although, it cannot be excluded that the diverse
expression pattern of DCAMLK1 is unrelated to stem
cell properties, our findings may indicate that eutopic
upregulation of DCAMLK1 may be of importance for
endometriotic cell survival before the establishment of
endometriotic lesions.
The correlation of stem cell factors with menstrual
cycle is controversial. It has been reported that the
number of clonogenic epithelial and stromal cells did
not vary between proliferative and secretory endomet-
rium in women without endometriosis [6]. Further-
more, most studies did not find a correlation between
the expression of stemness-related factors and the
phase of the menstrual cycle [19, 20, 26, 34]. This is in
concordance with our findings showing no correlation
between the epithelial or stromal expression of the
stemness-related markers DCAMLK1, OCT4, SOX15
and TWIST1 and the cycle phase of endometriosis pa-
tients, neither in EP endometrium nor in endometrio-
tic lesions. In contrast, few studies found an increased
expression of stemness-related markers, such as SOX2
or Musashi-1, in proliferative phase [33, 34]. However,
in patients without endometriosis, we found signifi-
cantly higher epithelial expression of DCAMLK1 in
the proliferative cycle phase than in the secretory
phase whereas the expression levels of epithelial
OCT4, SOX15 and TWIST1 are rather reduced in the
proliferative phase of patients without endometriosis.
Therefore, it has to be pointed out that some differ-
ences of the expression levels of stemness-related fac-
tors between endometrium of controls and patients
may be hormonally related. Generally, an upregulation
of stemness-related factors in normal endometrium
possibly prepares the tissue for renewal by accumula-
tion of pluripotent cells in the end of the menstrual
cycle.
Lastly, it must be mentioned that even for the estab-
lished stem cell marker OCT4 a formal proof of stem
cell property is still lacking in endometriotic cells. Thus
in endometriotic cells colony forming assays after trans-
duction or knockdown of these stemness-related factors
would be of great interest.
Conclusion
In conclusion, the results reported herein suggest that in
endometriosis SOX15 and TWIST1 may be stemness-
related markers as their expression correlates with OCT4
expression. The epithelial expression of OCT4, SOX15
and TWIST1 is increased in endometriotic tissue com-
pared to EP endometrium in paired and unpaired analysis
supporting the hypothesis that upregulation of stem cell-
related markers contribute to the establishment of ectopic
endometriotic lesions.
Additional file
Additional file 1: Quantitative Real Time PCR was used to analyze the
mRNA expression levels of DCAMLK1. Representative qRT-PCR results (Ct
values) for DCAMLK1 and control genes (ACTB and GAPDH) are shown.
(DOCX 216 kb)
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